PI Industries Limited CC-Jun24.pdf · 2024-08-08
Is it possible to share the breakup of the order book of $1.75 billion between Agrochem and non-Agrochem? And similarly, in the share of new products, would it be possible to share the breakup between Agrochem and new products and non - Agrochem segments?
Second thing is, on the domestic business, despite the strong growth in bio logical, there is a decline. I understand there is a seasonal impact on the other portfolio. And if you see the balance sheet details given in your annual report for Jivagro, while the gross margins have improved, the revenue has gone down, and it is possible to earn less than 10% of the net margin in ROE. So, like Jivagro, do you see any measures you are taking which will help you improve performance over the next 1- 2 years? And similarly, in terms of the new product launches for the domestic business, what is the kind of pipeline you have for the year in domestic formulation, excluding Jivagro and how many new products you are planning in Jivagro?